REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Satya Abadi Pharma (Indonesia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pt Satya Abadi Pharma Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Satya Abadi Pharma is an enterprise located in Indonesia, with the main office in Tangerang. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on August 04, 2011. In its most recent financial highlights, the company reported a net sales revenue increase of 12.84% in 2024. During that time, Pt Satya Abadi Pharma’s total assets grew by 10.41%.

Headquarters
Ruko Bintaro Jaya Sextor IX, Blok H6 & H7
Tangerang; Banten; Postal Code: 15229

Contact Details: Purchase the Pt Satya Abadi Pharma report to view the information.

Website: http://sapharma.co.id

Basic Information
Registered Capital:
Purchase the Pt Satya Abadi Pharma report to view the information.
Financial Auditors:
Purchase the Pt Satya Abadi Pharma report to view the information.
Incorporation Date:
August 04, 2011
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Satya Abadi Pharma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
12.84%
Total Operating Revenue
12.84%
Total Assets
10.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?